Concerns of secondary fever in Streptococcus pneumoniae meningitis in an era of increasing antibiotic resistance.
Esterle
T M
TM
Vanderbilt University School of Medicine, Nashville, TN 37232-2581, USA.
Edwards
K M
KM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000187:drug effects / Q000382:microbiology*; D002648:Child; D002675:Child, Preschool; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005334:Fever / Q000134:cerebrospinal fluid / Q000382:microbiology*; D006801:Humans; D008586:Meningitis, Pneumococcal / Q000134:cerebrospinal fluid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003907:Dexamethasone